A Epidemiological Profile of Mycoplasma Hominis and Ureaplasma Urealyticum Mycoplasmas at the University of N’Djamena Teaching Hospital (CHU-R)

Authors

  • Mahamat Alio Hamit Faculté des Sciences de la Santé Humaine

DOI:

https://doi.org/10.14738/jbemi.92.12119

Keywords:

Keyword: Mycoplasma, resistance, antibiotic, University Hospital of La Renaissance in N'Djamena (Chad).

Abstract

Mycoplasmas are very small bacteria without a wall. Mycoplasma hominis and Ureaplasma urealyticum are commensal germs of the urogenital tract, where they are frequently observed without their presence being of a pathological nature. To consider their pathogenicity and express their genitourinary infection, these two species must be isolated at a high concentration. The objective of this study was to determine the role of these two mycoplasmas in human pathology, their resistance to antibiotics and also to better understand these bacteria and to assess their intervention in genital infections. This is a retrospective descriptive and analytical study started from 2017 to 2021 at the laboratory of University Hospital of La Renaissance in N'Djamena (Chad). Analyses of all the records showed that among 342 patients performed Mycoplasma examinations 240 were male with a sex ratio of 2.35 (M/F). Among all the patients, 92 were infected by Mycoplasmas with the prevalence rate of 27%. Analysis of samples from infected patients shows the presence of: U. urealyticum in 68 patients (74%), M. hominis in 10 patients (10.87%) and co-infection of the two species in 14 patients (15.21%). The study confirmed that the most age group infected in this study was the age group [0-25]. The resistance of each positive case was observed in the Mycoplasma IST3 gallery. The strain of U. urealyticum showed the resistance to all molecules. These resistances are less than 20% for floroquinolone Moxifloxacin, and this resistance was greater than 20% for the other molecules. On the other hand, M. hominis was sensitive to Tetracycline and macrolide Telithromycin, although resistance to floroquinolones Levofloxacin and Moxifloxacin was 20% and 80% respectively. In the case of co-infection have presented various resistances to all molecules, the smallest was Levrofloxacin with the prevalence of 21.42%. These variations of resistance justify the interest of identification of these two species and the study their sensitivity for a good management of these infections.

Keyword: Mycoplasma, resistance, antibiotic, University Hospital of La Renaissance in N'Djamena (Chad).

 

References

. Cazanave C, Manhart L, Bébéar C. Mycoplasma genitalium, an emerging sexually transmitted pathogen. Médecine et maladies infectieuses. 2012;42(9):381-392.

. Taylor-Robinson D, Jensen JS. Mycoplasma genitalium: From chrysalis to multicolored butterfly. Clin Microbiol Rev. 2011;24(3):498-514. doi: 10.1128/CMR.00006-11 [doi].

. Askienazy-Elbhar M. Male genital tract infection: the point of view of the bacteriologist. GynecolObstetFertil. 2005; 33(9):691-7.

. Elena Moretti, Serena Capitani, Natale Figura, Andrea Pammolli, Maria Grazia Federico,Valentina Giannerini et al. The presence of bacteria species in semen and sperm quality. J Assist Reprod Genet.2009 Jan; 26(1): 47-56.

. Schuppe HC, Pilatz A, Hossain H, Diemer T, Wagenlehner F, Weidner W et al. Urogenital Infection as a Risk Factor for Male Infertility. Dtsch Arztebl Int. 2017 May 12;114(19):339.

. Hannachi H, Elloumi H, Hamdoun M, Kacem K, Zhioua A, Bahri O et al. Bacteriospermia: effects on semen parameters. Gynecol Obst et Fertil Senol. 2018 Jun;46(6):518-523.

. Jungwirth A, Straberger B, Esterbauer K, Fink K, Schmeller N. Acrosome reaction in chlamydia positive and negative patients. Andrologia. 2003 Oct; 35(5):314-6.

. Frikh M, Mrimar N, Kasouati J, Hamzaoui A, Maleb A, Lemnouer A et al. Prevalence and roleogfIgG anti-Chlamydia trachomatis in a population of infertile men in Morocco. ProgUrol. 2019 Oct; 29(12):612-618.

. Bébéar C, De Barbeyrac B, Pereyre S, Bébéar C M . Résistance aux antibiotiques chez les mycoplasmes et les chlamydiae. Antibiotiques 2004; 6 : 263-265

. Diaz L, Cabrera LE, Fernandez T, Ibanez I, Torres Y, Obregon Y, Rivero Y. 2013. Frequency and antimicrobial sensitivity of Ureaplasma urealyticum and Mycoplasma hominis in patients with vaginal discharge. MEDICC Rev., 15(4): 45-47.

. Diop-N’diaye H, Gueye M, Camara M, Gueye SB, Ba-Diallo A, Karam F, Diagne Samb H, Fall-Niang MY, Diouf O, Toure-Kane NC, Mboup S, Gaye-Diallo A. 2014. Sensibilité aux antibiotiques de Mycoplasma hominis et de Ureaplasma urealyticum isolées du tractus génital de femmes à Dakar. Dakar Med., 59(3): 177-184.

. Bébéar C, Bébéar C.M. Infection humaine à mycoplasmes. Revue francophone des laboratoires 2007 ; 391 :64-66

. Diaz, N., Dessì, D., Dessole, S., Fiori, P. L., and Rappelli, P. (2010). Rapid detection of coinfections by Trichomonas vaginalis, Mycoplasma hominis, and Ureaplasma urealyticum by a new multiplex polymerase chain reaction. Diagn. Microbiol. Infect. Dis. 67, 30–36. doi: 10.1016/j.diagmicrobio.2009.12.022.

. Rumyantseva, T., Khayrullina, G., Guschin, A., and Donders, G. (2019). Prevalence of ureaplasma spp. and Mycoplasma hominis in healthy women and patients with flora alterations. Diagn. Microbiol. Infect. Dis. 93, 227–231. doi: 10.1016/j.diagmicrobio.2018.10.001.

. Fettweis, J. M., Serrano, M. G., Huang, B., Brooks, J. P., Glascock, A. L., Sheth, N. U., et al. (2014). An emerging mycoplasma associated with trichomoniasis, vaginal infection and disease. PLoS ONE 9:e110943. doi: 10.1371/journal.pone.0110943.

. Taylor-Robinson, D. (2017). Mollicutes in vaginal microbiology: Mycoplasma hominis, Ureaplasma urealyticum, Ureaplasma parvum and Mycoplasma genitalium. Res. Microbiol. 168, 875–881. doi: 10.1016/j.resmic.2017. 02.009.

. Alcaraz I, Dupin N, Janier M et al. Mycoplasmes génitaux. Ann Dermatol Venereol 2006; 133: 2S17-8.

. Onderdonk, A. B., Delaney, M. L., and Fichorova, R. N. (2016). The human microbiome during bacterial vaginosis. Clin. Microbiol. Rev. 29, 223–238. doi: 10.1128/CMR.00075-15.

. Taylor-Robinson, D., and Lamont, R. F. (2011). Mycoplasmas in pregnancy. BJOG. 118, 164–174. doi: 10.1111/j.1471-0528.2010. 02766.x

. Cox C, Saxena N, Watt AP, Gannon C, Mc Kenna JP, Fairley DJ, et al. The common vaginal commensal bacterium Ureaplasma parvum is associated with chorioamnionitis in extreme preterm labor. J Matern Fetal Neonatal Med. 2016;26:1-6.

. Kataoka S, Yamada T, Chou K et al. Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy. J Clin Microbiol. 2006;44(1):51-5.

. Kwak DW, Hwang HS, Kwon JY, Park YW, Kim YH. Co-infection with vaginal Ureaplasma urealyticum and Mycoplasma hominis increases adverse pregnancy outcomes in patients with preterm labor or preterm premature rupture of membranes. J. Matern. Fetal Neonatal Med. 2014;27(4):333-7. doi: 10.3109/14767058.2013.818124.

. Capoccia R, Greub G, Baud D. Ureaplasma urealyticum, Mycoplasma hominis and adverse pregnancy outcomes. Curr Opin Infect Dis. 2013;26(3):231-40. doi: 10.1097/QCO.0b013e328360db58.

. Haggerty CL, Totten PA, Tang G Astete SG, Ferris MJ, Norori J, et al. Identification of novel microbes associated with pelvic inflammatory disease and infertility. Sex Transm Infect. 2016;92(6):441-6. doi: 10.1136/sextrans-2015-052285.

. Gandji S, Bankole HS, Dougnon TV, Da Silva J, Zannou C, Biaou O. 2013. Survenue des obstructions tubaires chez les femmes à Cotonou (Bénin) : rôle des bactéries. Int. J. Biol. Chem. Sci., 7(3): 1338-1343. DOI: http://dx.doi.org/10.4314/ijbcs.v7i3.39

. Xiaofei Z, Min L, Huiling C, Xuewen Y, Chunbing Z. 2016. Epidemiology of Ureaplasma urealyticum and Mycoplasma hominis in the semen of male out patients with reproductive disorders. Exp Ther Med., 12(2): 11651170. DOI: 10.3892/etm.2016.3409.

. T. B. Kouassi-Agbessi, A. M. Cablan, A. G. Krizo, N. Y. Zinzendorf et C. N. Amin. (2019). Etude de la sensibilité aux antibiotiques des mycoplasmes isolés de spermes à Abidjan. Int. J. Biol. Chem. Sci. 13(3): 1558-1564.

. Karou SD, Djigma F, Sagna T, Nadembega C, Zeba M, Kabre A, Anani K, Ouermi D, Gnoula C, Pietra V, Pigatelli S, Simpore J. 2012. Antimicrobial resistance of abnormal vaginal discharges microorganisms in Ouagadougou, Burkina Faso. Asian Pac J Trop Biomed., 2(4): 294-297.

. Diop-N’diaye H, Gueye M, Camara M, Gueye SB, Ba-Diallo A, Karam F, DiagneSamb H, Fall-Niang MY, Diouf O, Toure-Kane NC, Mboup S, Gaye-Diallo A. 2014. Sensibilité aux antibiotiques de Mycoplasma hominis et de Ureaplasma urealyticum isolées du tractus génital de femmes à Dakar. Dakar Med., 59(3): 177-184.

. Ouegnin GA, Gnagne YM, Vodi CC, Faye Kette H, N’douba KA, Tchetche RG.2008. Rôle des germes de l’infection génitale dans l’infertilité masculine. Revue Bio-Africa., 6: 32-38.

. Zhu C, Liu J, Ling Y, Dong C, Wu T, Yu X, Hou Y, Dong L, Cheng X. 2012. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in Chinese women with genital infectious diseases. Indean J Dermatol Venereol Leprol., 78(3) : 406-407. DOI: 10.4103/0378-6323.95480.

. De Francesco MA, Caracciolo S, Bonfanti C, Manca N. 2013. Incidence and antibiotic susceptibilty of Mycoplasma hominis and Ureaplasma urealyticum isolated in Brescia, Italy, over 7 years. J Infect Chemother., 19(4) : 621-627. DOI: 10.1007/s10156-012-0527-z

. Hounsa A, Kouadio L, De Mol P. 2010. Automédication par les antibiotiques provenant des pharmacies privées de la ville d’Abidjan en Côte d’Ivoire. Med Mal Infect., 4(6) : 333-340. Doi : 10.1016/j.medmal.2009.10.002.

. Hailaji NSM, Ould Salem ML, Ghaber SM. 2016. La sensibilité aux antibiotiques des bactéries uropathogènes dans la ville de Nouakchott-Mauritanie. Prog Urol. 26(6): 346-352. DOI: https://doi.org/10.1016/j.purol.2016.04.004.

Downloads

Published

2022-04-11

How to Cite

Hamit, M. A. (2022). A Epidemiological Profile of Mycoplasma Hominis and Ureaplasma Urealyticum Mycoplasmas at the University of N’Djamena Teaching Hospital (CHU-R). British Journal of Healthcare and Medical Research, 9(2), 88–97. https://doi.org/10.14738/jbemi.92.12119